title: [The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].
abstract: The results of combined treatment including intraoperative radiation therapy (IORT) were assessed in 147 patients with stage III non-small cell lung cancer. Preoperative chemotherapy with paclitaxel/carboplatin followed by surgery with 15 Gy IORT and additional administration of radiosensitization with cisplatin resulted in a significant increase in the 5-year survival rate compared to surgery alone (39.2% and 47.9%, versus 29.2%, p<0.05).
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Dobrodeev
authors.forename: A A
authors.initials: AA
authors.lastname: Zav'ialov
authors.forename: S A
authors.initials: SA
authors.lastname: Tyzikov
authors.forename: L I
authors.initials: LI
authors.lastname: Musabaeva
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D017239:Paclitaxel / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin